Expanded Access (Compassionate Use) For patients with serious/life-threatening disease Who have exhausted ALL approved treatments Requires FDA approval Very narrow circumstances Prescribing BPC-157 for a sprained ankle
Nervicin is approved by the DCGI to ensure the quality and match the international standards
known trial-reported adverse effects include gastrointestinal symptoms, injection site reactions, increased heart rate, and hypoglycaemia risk
In StatPearls Internet
If you need to change the day of your weekly injection, you can, so as long as it has been at least 3 days since your last injection
They're often cited in healthspan discussions because large RCTs show benefits on major agerelated diseases including cardiovascular disease, kidney disease, obesity related heart failure and type 2 diabetes, Parkinson's disease progression, and dementia/cognitive impairment